Background
Methods
Results
AFFLUENT n (%) | DEPRIVED n (%) | Chi squared test result | ||||
---|---|---|---|---|---|---|
PATHOLOGICAL PROGNOSTIC FACTORS | ||||||
SIZE* |
WHOLE SAMPLE
n = 136
|
CONSENTED SAMPLE
n = 72
|
WHOLE SAMPLE
n = 194
|
CONSENTED SAMPLE
n = 91
|
WHOLE SAMPLE
|
CONSENTED SAMPLE
|
0 – 19 mm
| 70 (51.5%) |
42 (58.3%)
| 106 (54.6%) |
54 (59.3%)
|
X
2
= 0.53
|
X
2
= 0.04
|
20 – 49 mm
| 62 (45.6%) |
29 (40.3%)
| 81 (41.8%) |
36 (39.6%)
|
DF = 2
|
DF = 2
|
>50 mm
| 4 (2.9%) |
1 (1.4%)
| 7 (3.6%) |
1 (1.1%)
|
p = 0.76
|
p = 0.98
|
GRADE*
|
n = 110
|
n = 59
|
n = 156
|
n = 72
| ||
1
| 17 (15.5%) |
9 (15.3%)
| 30 (19.2%) |
18 (25.0%)
|
X
2
= 0.66
|
X
2
= 1.83
|
2
| 67 (60.9%) |
39 (66.1%)
| 92 (59.0%) |
42 (58.3%)
|
DF = 2
|
DF = 2
|
3
| 26 (23.6%) |
11 (18.6%)
| 34 (21.8%) |
12 (16.7%)
|
p = 0.72
|
p = 0.34
|
NODAL STATUS*
|
n = 128
|
n = 72
|
n = 196
|
n = 93
| ||
Positive
| 48 (37.5%) |
24 (33.3%)
| 72 (36.7%) |
28 (30.1%)
|
X
2
= 0.01
|
X
2
= 0.196
|
Negative
| 80 (62.5%) |
48 (66.6%)
| 124 (63.3%) |
65 (69.9%)
|
DF = 1
p = 0.88
|
DF = 2
p = 0.736
|
CLINICAL STAGE AT PRESENTATION
| ||||||
n = 156
|
n = 260
| |||||
Early
| 146 (93.6%) |
100%
| 220 (84.6%) |
100%
|
X
2
= 7.42
|
N/A
|
Locally advanced or metastatic
| 10 (6.4%) | 40 (15.4%) |
DF = 1
p = 0.006
|
AFFLUENT n (%) | DEPRIVED n (%) | Chi squared test result | ||||
---|---|---|---|---|---|---|
WHOLE SAMPLE
|
CONSENTED SAMPLE
|
WHOLE SAMPLE
|
CONSENTED SAMPLE
|
WHOLE SAMPLE
|
CONSENTED SAMPLE
| |
BREAST SURGERY
|
n = 142*
|
n = 75**
|
n = 215*
|
n = 97**
| ||
Mastectomy | 64 (45.1%) |
37 (49.3%)
| 104 (48.4%) |
43 (44.3%)
| X2 = 0.37 DF = 3 |
X
2
= 0.43 DF = 1
|
Conservation | 78 (54.9%) |
38 (50.7%)
| 111 (51.6%) |
54 (55.7%)
| p = 0.54 |
p = 0.54
|
AXILLA SURGERY
|
n = 129*
|
n = 70*
|
n = 196 *
|
n = 94**
| ||
Clearance | 123 (95.3%) |
68 (97.1%)
| 146 (74.5%) |
69 (73.4%)
| X2 = 23.73 DF = 1 |
X
2
= 16.4 DF = 1
|
Sampling | 6 (4.7%) |
2 (2.9%)
| 50 (25.5%) |
25 (36.6%)
| p = 0.0000 |
p = 0.000
|
RADIOTHERAPY
|
n = 146
54 (37.0%) |
n = 72**
22 (30.6%)
|
n = 220
90 (40.9%) |
n = 98**
50 (51.0%)
| X2 = 0.56 DF = 1 p = 0.45 |
X
2
= 5.82 DF = 1 p = 0.018
|
CHEMOTHERAPY
|
n = 146
29 (19.9%) |
n = 75**
13 (16.9%)
|
n = 220
30 (13.6%) |
n = 100**
15 (15%)
| X2 = 2.51 DF = 1 p = 0.11 |
X
2
= 0.116 DF = 1 p = 0.84
|
ENDOCRINE THERAPY
|
n = 146
128 (87.7%) |
n = 77
71 (92.2%)
|
n = 220
196 (89.1%) |
n = 100
92 (92.0%)
| X2 = 0.17 DF = 1 p = 0.67 |
X
2
= 0.003 DF = 1 p = 1.0
|